Ed Copelan

470 total citations
13 papers, 324 citations indexed

About

Ed Copelan is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ed Copelan has authored 13 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 5 papers in Molecular Biology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ed Copelan's work include Acute Myeloid Leukemia Research (7 papers), Acute Lymphoblastic Leukemia research (5 papers) and Histone Deacetylase Inhibitors Research (4 papers). Ed Copelan is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Acute Lymphoblastic Leukemia research (5 papers) and Histone Deacetylase Inhibitors Research (4 papers). Ed Copelan collaborates with scholars based in United States, France and Saudi Arabia. Ed Copelan's co-authors include Anjali S. Advani, Mikkael A. Sekeres, Ronald Sobecks, Sergio Giralt, Paul Shaughnessy, John R. Wingard, Richard E. Champlin, Corey Cutler, William Bensinger and Paul A. Carpenter and has published in prestigious journals such as Blood, Clinical Cancer Research and British Journal of Haematology.

In The Last Decade

Ed Copelan

13 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ed Copelan United States 8 221 122 70 66 42 13 324
Cristina Barrenetxea Spain 5 203 0.9× 82 0.7× 108 1.5× 63 1.0× 35 0.8× 6 291
D.C. Setubal Brazil 9 302 1.4× 100 0.8× 82 1.2× 85 1.3× 95 2.3× 21 390
Stoppa Am France 11 290 1.3× 96 0.8× 136 1.9× 68 1.0× 49 1.2× 18 350
Maria Saduś‐Wojciechowska Poland 10 182 0.8× 42 0.3× 58 0.8× 47 0.7× 66 1.6× 25 277
DJ Inwards United States 8 238 1.1× 54 0.4× 110 1.6× 30 0.5× 29 0.7× 9 298
D. Niederwieser Germany 8 246 1.1× 50 0.4× 63 0.9× 102 1.5× 80 1.9× 14 334
Tiziana Moscato Italy 13 269 1.2× 86 0.7× 174 2.5× 29 0.4× 40 1.0× 33 339
A. Ferster Belgium 9 232 1.0× 65 0.5× 76 1.1× 36 0.5× 51 1.2× 11 370
Shin‐ichi Fuchida Japan 11 169 0.8× 87 0.7× 107 1.5× 17 0.3× 44 1.0× 38 294
Fahad Alsharif Saudi Arabia 9 133 0.6× 66 0.5× 89 1.3× 114 1.7× 32 0.8× 30 326

Countries citing papers authored by Ed Copelan

Since Specialization
Citations

This map shows the geographic impact of Ed Copelan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ed Copelan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ed Copelan more than expected).

Fields of papers citing papers by Ed Copelan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ed Copelan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ed Copelan. The network helps show where Ed Copelan may publish in the future.

Co-authorship network of co-authors of Ed Copelan

This figure shows the co-authorship network connecting the top 25 collaborators of Ed Copelan. A scholar is included among the top collaborators of Ed Copelan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ed Copelan. Ed Copelan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Hamadeh, Issam S., Jai N. Patel, Ryan Jacobs, et al.. (2023). Genetic Predictors of Ibrutinib-related Cardiovascular Side Effects in Patients with Chronic Lymphocytic Leukemia. Clinical Cancer Research. 29(23). 4941–4948. 4 indexed citations
2.
Duong, Hien K., Bipin N. Savani, Ed Copelan, et al.. (2014). Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation. 20(9). 1262–1273. 140 indexed citations
3.
Saunthararajah, Yogen, Pierre L. Triozzi, Brian I. Rini, et al.. (2012). p53-Independent, Normal Stem Cell Sparing Epigenetic Differentiation Therapy for Myeloid and Other Malignancies. Seminars in Oncology. 39(1). 97–108. 39 indexed citations
4.
Rose, Jonathan A., Michaela Liedtke, Paul Elson, et al.. (2012). Impact of Day 28 Absolute Lymphocyte Count On Outcome of Hematopoietic Cell Transplant (HCT) in CR1 for Adult Patients with Acute Lymphoblastic Leukemia. Blood. 120(21). 1472–1472. 1 indexed citations
5.
Ng, Kwok Peng, Quteba Ebrahem, Soledad Negrotto, et al.. (2011). p53 Independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia. Leukemia. 25(11). 1739–1750. 51 indexed citations
6.
Advani, Anjali S., Sarah Gibson, Elizabeth Douglas, et al.. (2011). Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL). British Journal of Haematology. 153(4). 504–507. 8 indexed citations
7.
Kalaycio, M, Brian J. Bolwell, Lisa Rybicki, et al.. (2010). BU- vs TBI-based conditioning for adult patients with ALL. Bone Marrow Transplantation. 46(11). 1413–1417. 19 indexed citations
8.
Advani, Anjali S., Mazyar Shadman, Francis Ali‐Osman, et al.. (2010). A Phase II Trial of Gemcitabine and Mitoxantrone for Patients With Acute Myeloid Leukemia in First Relapse. Clinical Lymphoma Myeloma & Leukemia. 10(6). 473–476. 16 indexed citations
9.
Advani, Anjali S., Elizabeth Douglas, Tao Jin, et al.. (2010). Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients. BMC Cancer. 10(1). 387–387. 20 indexed citations
10.
Advani, Anjali S., Tao Jin, Giridharan Ramsingh, et al.. (2008). Time to post-remission therapy is an independent prognostic factor in adults with acute lymphoblastic leukemia. Leukemia & lymphoma. 49(8). 1560–1566. 4 indexed citations
11.
12.
Copelan, Ed, et al.. (1995). Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide.. PubMed. 15(1). 105–10. 18 indexed citations
13.
Keever, C, Isabel Cunningham, Ed Copelan, et al.. (1991). Hla-b44.2 directed cytotoxic t cells associated with acute graft vs host disease following unrelated marrow transplantation. Human Immunology. 32. 76–76. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Barrenetxea Breakdown of academic impact, for papers by D.C. Setubal Breakdown of academic impact, for papers by Stoppa Am Breakdown of academic impact, for papers by Maria Saduś‐Wojciechowska Breakdown of academic impact, for papers by DJ Inwards Breakdown of academic impact, for papers by D. Niederwieser Breakdown of academic impact, for papers by Tiziana Moscato Breakdown of academic impact, for papers by A. Ferster Breakdown of academic impact, for papers by Shin‐ichi Fuchida Breakdown of academic impact, for papers by Fahad Alsharif
Rankless by CCL
2026